ArticleMicrobial cell factories2025
Antibacterial, antibiofilm, and antiproliferative properties of Aspergillus frequens-derived pigment.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFilamentous fungi produce a broad spectrum of colored secondary metabolites that are largely used in various industries, including food, cosmetics, fabrics, and medications. This study explores, for the first time, the potential of Aspergillus frequens to produce pigmented secondary metabolites and their application in various biotechnological treatments.
resultsAspergillus frequens (Asmaa 2024) produced the highest concentration of pigmented secondary metabolites among the 20 tested fungal rhizospheric fungi, reaching 21.36 ± 1.8 AU/mL in potato dextrose broth (PDB) medium. Scanning electron microscopy (SEM) revealed that the extracted pigment has an irregular shape and particle size, ranging from 40 to 184 nm. The elemental composition revealed the presence of high ratios of carbon and oxygen using energy-dispersive X-ray (EDX). Many functional groups and chromophore compounds have been detected in the extracted pigment using Fourier-transform infrared spectroscopy (FT-IR) and gas chromatography-mass spectrometry (GC-MS). Thirteen pathogenic species of bacteria were significantly inhibited in their development by the colored metabolites, whose minimum bactericidal concentrations (MBCs) varied from 4.5 to 16.7 mg/mL. The most notable percentages in suppression biofilm development, suggesting a major influence, were 66.8% for Klebsiella pneumoniae and 64.8% for Bacillus subtilis using the microtiter plate technique. Following assessment of zeta potential, particle size, and polydispersity index (PDI) of the target bacteria, the effective antibacterial efficacy of the pigmented secondary metabolites was confirmed. The viability of the osteosarcoma (HOS) and lung cancer (A549) cell lines was significantly diminished by the A. frequens' secondary metabolites, with IC50 values of 43.3 and 77.1 µg/mL, respectively. In contrast, the skin cancer cell line (A431) showed no signs of impact, using the MTT assay.
conclusionBased on the obtained findings, A. frequens pigmented secondary metabolites have promising potential in the biological control of pathogenic and biofilm-forming bacteria, as well as in the treatment of bone and lung cancer. While numerous studies have investigated pigment production in Aspergillus species, this research represents the first investigation into pigment synthesis by A. frequens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.